The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Thousands feared dead after two major earthquakes strike Venezuela
Trump asks Congress for more funds to fight Iran, defying rebuke on war powers
Magnitude 6.9 quake strikes Japan's northeast, no tsunami warning
US, Iran at odds on nuclear inspections, frozen assets in deal to end war
Oman establishes temporary shipping corridor through Strait of Hormuz
